Toth Financial Advisory Corp Increases Stake in iShares Biotechnology ETF $IBB

Toth Financial Advisory Corp raised its holdings in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 12.7% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 42,261 shares of the financial services provider’s stock after acquiring an additional 4,762 shares during the quarter. Toth Financial Advisory Corp’s holdings in iShares Biotechnology ETF were worth $8,038,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds have also recently modified their holdings of IBB. Citigroup Inc. lifted its position in iShares Biotechnology ETF by 40.9% during the fourth quarter. Citigroup Inc. now owns 5,242,688 shares of the financial services provider’s stock valued at $884,808,000 after purchasing an additional 1,521,992 shares in the last quarter. Raymond James Financial Inc. grew its stake in shares of iShares Biotechnology ETF by 286.2% during the 4th quarter. Raymond James Financial Inc. now owns 994,311 shares of the financial services provider’s stock valued at $167,810,000 after acquiring an additional 736,881 shares during the period. Bank of America Corp DE increased its holdings in iShares Biotechnology ETF by 10.8% in the 1st quarter. Bank of America Corp DE now owns 7,259,501 shares of the financial services provider’s stock worth $1,225,767,000 after acquiring an additional 707,343 shares in the last quarter. Truist Financial Corp increased its holdings in iShares Biotechnology ETF by 2,239.6% in the 4th quarter. Truist Financial Corp now owns 642,023 shares of the financial services provider’s stock worth $108,354,000 after acquiring an additional 614,582 shares in the last quarter. Finally, LPL Financial LLC raised its stake in iShares Biotechnology ETF by 145.9% during the 4th quarter. LPL Financial LLC now owns 992,799 shares of the financial services provider’s stock worth $167,555,000 after acquiring an additional 589,033 shares during the period. Institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Performance

NASDAQ IBB opened at $208.95 on Friday. iShares Biotechnology ETF has a 12 month low of $137.63 and a 12 month high of $217.12. The company’s 50 day moving average is $195.01 and its two-hundred day moving average is $178.87.

iShares Biotechnology ETF Cuts Dividend

The company also recently announced a quarterly dividend, which was paid on Thursday, June 18th. Investors of record on Monday, June 15th were paid a dividend of $0.0238 per share. The ex-dividend date was Monday, June 15th. This represents a $0.10 dividend on an annualized basis and a dividend yield of 0.0%.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.